Huddleston Daniel E, Chen Xiangchuan, Hwang Kristy, Langley Jason, Tripathi Richa, Tucker Kelsey, McKay J Lucas, Hu Xiaoping, Factor Stewart A
Jean and Paul Amos Parkinson's Disease and Movement Disorder Program, Department of Neurology, Emory University, Atlanta, GA, United States.
Department of Neurology, University of California, San Diego, La Jolla, CA, United States.
Front Dement. 2023 Aug 11;2:1215505. doi: 10.3389/frdem.2023.1215505. eCollection 2023.
Substantia nigra pars compacta (SNc) and locus coeruleus (LC) are neuromelanin-rich nuclei implicated in diverse cognitive and motor processes in normal brain function and disease. However, their roles in aging and neurodegenerative disease mechanisms have remained unclear due to a lack of tools to study them . Preclinical and post-mortem human investigations indicate that the relationship between tissue neuromelanin content and neurodegeneration is complex. Neuromelanin exhibits both neuroprotective and cytotoxic characteristics, and tissue neuromelanin content varies across the lifespan, exhibiting an inverted U-shaped relationship with age. Neuromelanin-sensitive MRI (NM-MRI) is an emerging modality that allows measurement of neuromelanin-associated contrast in SNc and LC in humans. NM-MRI robustly detects disease effects in these structures in neurodegenerative conditions, including Parkinson's disease (PD). Previous NM-MRI studies of PD have largely focused on detecting disease group effects, but few studies have reported NM-MRI correlations with phenotype. Because neuromelanin dynamics are complex, we hypothesize that they are best interpreted in the context of both disease stage and aging, with neuromelanin loss correlating with symptoms most clearly in advanced stages where neuromelanin loss and neurodegeneration are coupled. We tested this hypothesis using NM-MRI to measure SNc and LC volumes in healthy older adult control individuals and in PD patients with and without freezing of gait (FOG), a severe and disabling PD symptom. We assessed for group differences and correlations between NM-MRI measures and aging, cognition and motor deficits. SNc volume was significantly decreased in PD with FOG compared to controls. SNc volume correlated significantly with motor symptoms and cognitive measures in PD with FOG, but not in PD without FOG. SNc volume correlated significantly with aging in PD. When PD patients were stratified by disease duration, SNc volume correlated with aging, cognition, and motor deficits only in PD with disease duration >5 years. We conclude that in severe or advanced PD, identified by either FOG or disease duration >5 years, the observed correlations between SNc volume and aging, cognition, and motor function may reflect the coupling of neuromelanin loss with neurodegeneration and the associated emergence of a linear relationship between NM-MRI measures and phenotype.
黑质致密部(SNc)和蓝斑(LC)是富含神经黑色素的核团,在正常脑功能和疾病中的多种认知和运动过程中发挥作用。然而,由于缺乏研究它们的工具,它们在衰老和神经退行性疾病机制中的作用仍不清楚。临床前和死后人体研究表明,组织神经黑色素含量与神经退行性变之间的关系很复杂。神经黑色素具有神经保护和细胞毒性特征,并且组织神经黑色素含量在整个生命周期中会发生变化,与年龄呈倒U形关系。神经黑色素敏感磁共振成像(NM-MRI)是一种新兴的成像方式,可用于测量人体SNc和LC中与神经黑色素相关的对比度。NM-MRI能可靠地检测神经退行性疾病(包括帕金森病(PD))中这些结构的疾病影响。先前关于PD的NM-MRI研究主要集中在检测疾病组效应,但很少有研究报道NM-MRI与表型的相关性。由于神经黑色素的动态变化很复杂,我们假设它们最好在疾病阶段和衰老的背景下进行解释,在神经黑色素丢失与神经退行性变耦合的晚期阶段,神经黑色素丢失与症状的相关性最为明显。我们使用NM-MRI测量健康老年对照个体以及有和没有冻结步态(FOG,一种严重且致残的PD症状)的PD患者的SNc和LC体积,来验证这一假设。我们评估了组间差异以及NM-MRI测量值与衰老、认知和运动缺陷之间的相关性。与对照组相比,伴有FOG的PD患者的SNc体积显著减小。伴有FOG的PD患者的SNc体积与运动症状和认知指标显著相关,但在不伴有FOG的PD患者中则不然。PD患者的SNc体积与衰老显著相关。当根据疾病持续时间对PD患者进行分层时,仅在疾病持续时间>5年的PD患者中,SNc体积与衰老、认知和运动缺陷相关。我们得出结论,在由FOG或疾病持续时间>5年所确定的严重或晚期PD中,观察到的SNc体积与衰老、认知和运动功能之间的相关性可能反映了神经黑色素丢失与神经退行性变的耦合以及NM-MRI测量值与表型之间相关线性关系的出现。